| NSC | Compound | Enrichment | Correlation |
|---|---|---|---|
| NSC 695788 | N(sup .alpha.)-[4-[(2,4-Diamino-5-methylpyrido[2,3-d] pyrimidin-6-yl)methyl]amino]benzoyl-n(sup .delta.)-hemiphthaloyl-L-ornithine | 4.24778409539024e-005 | 0.58812343 |
| NSC 755267 | Null | 4.24778409539024e-005 | 0.43559495 |
| NSC 225112 | 2,4,6-Quinazolinetriamine, N(6)-[(3,4-dichlorophenyl)methyl]-N(6)-ethyl-5-methyl- | 4.46503794379037e-006 | 0.77004647 |
| NSC 697194 | Decanediamide, N,N'-bis[2-(2-hydroxy-1-naphthalenyl)- 5-(3,4-dimethoxyphenyl)methylene]-4-oxo- 3-thiazolidinyl]- | 5.09419714526523e-005 | 0.24528565 |
| NSC 734307 | 3,4-Dihydroxy-N(3-O-methyl-estra-1,3,5(10)-trien-ol-17b-yl)c innamide | 5.09419714526523e-005 | 0.42198184 |
| NSC 752464 | methyl 2-((S,3Z)-6-((E)-1-hydroxy-3-phenylallylidene)-5-oxocyclohex-3-enyl)acetate | 5.09419714526523e-005 | 0.32816439 |
| NSC 757113 | METHOTREXATE(+/-) | 5.09419714526523e-005 | 0.67695647 |
| NSC 112846 | N-[p-[[(2,4-Diamino-6-quinazolinyl)methyl]amino]benzoyl]-L-aspartic acid | 5.09419714526527e-005 | 0.69419448 |
| NSC 675988 | 11H-[1]Benzothiopyrano[2,3-e]imidazo[1,2-a]pyridine- 2-carboxamide, N-[3-(dimethylamino)propyl]-11-oxo- | 5.26048017395702e-005 | 0.31550205 |
| NSC 351521 | Ethanesulfonic acid, 2-hydroxy-, compd. with 6-[(2,5-dimethoxyphenyl)methyl]-5-methylpyrido[2,3-d] pyrimidine-2,4-diamine (1:1) | 5.82211804338771e-005 | 0.66741126 |